Loss of SLCO1B3 drives taxane resistance in prostate cancer von de Morrée, Ellen S, Böttcher, René, van Soest, Robert J, Aghai, Ashraf, de Ridder, Corrina M, Gibson, Alice A, Mathijssen, Ron HJ, Burger, Herman, Wiemer, Erik AC, Sparreboom, Alex, de Wit, Ronald, van Weerden, Wytske M

Volltext

Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study von van Soest, Robert J, de Morrée, Ellen S, Shen, Liji, Tannock, Ian F, Eisenberger, Mario A, de Wit, Ronald

Volltext

Inter-patient variability in docetaxel pharmacokinetics: A review von Nieuweboer, Annemieke J.M, de Morrée, Ellen S, de Graan, Anne-Joy M, Sparreboom, Alex, de Wit, Ronald, Mathijssen, Ron H.J

Volltext

Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness von Wissing, Michel D, De Morrée, Ellen S, Dezentjé, Vincent O, Buijs, Jeroen T, De Krijger, Ronald R, Smit, Vincent T H B M, Van Weerden, Wytske M, Gelderblom, Hans, van der Pluijm, Gabri

Volltext

Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer von van Soest, Robert J, de Morrée, Ellen S, Kweldam, Charlotte F, de Ridder, Corrina M.A, Wiemer, Erik A.C, Mathijssen, Ron H.J, de Wit, Ronald, van Weerden, Wytske M

Volltext

Reply to Masaki Shiota and Akira Yokomizo's Letter to the Editor re: Robert J. van Soest, Ellen S. de Morrée, Charlotte F. Kweldam, et al. Targeting the Androgen Receptor Confers I... von van Soest, Robert J, de Morrée, Ellen S, Kweldam, Charlotte F, Wiemer, Erik A.C, Mathijssen, Ron H.J, de Wit, Ronald, van Weerden, Wytske M

Volltext

Abstract 255: Docetaxel inhibits testosterone mediated activation of the AR pathway by SLCO1B3 von de Morree, Ellen S., Aghai, Ashraf, Gibson, Alice A., Mathijssen, Ron H.J., Wiemer, Eric A.C., Sparreboom, Alex, van Weerden, Wytske M., de Wit, Ronald

Volltext

Abstract C68: SLCO1B3 influences taxane-response in prostate cancer von de Morree, Ellen S., Bottcher, Rene, van Soest, Robert J., Aghai, Ashraf, de Ridder, Corrina M., Gibson, Alice A., Mathijssen, Ron HJ, Burger, Herman, Wiemer, Erik AC, Sparreboom, Alex, van Weerden, Wytske M., de Wit, Ronald

Volltext

Abstract A99: Docetaxel-resistance can be overcome by enhancing intratumoral taxane concentrations to a threshold level for efficacy von de Morree, Ellen S., de Ridder, Corrina M., de Bruijn, Peter, Burger, Herman, Wiemer, Erik A.C., Mathijssen, Ron H.J., de Wit, Ronald, van Weerden, Wytske

Volltext

Abstract 316: Cabazitaxel antitumor activity in docetaxel-resistant patient-derived prostate cancer xenograft models von de Morree, Ellen S., de Ridder, Corrina M.A., Burger, Herman, Wiemer, Erik A.C., Mathijssen, Ron H.J., de Wit, Ronald, van Weerden, Wytske M.

Volltext

The in vivo efficacy of docetaxel and cabazitaxel in a cell-line based xenograft of castration-resistant prostate cancer (CRPC) previously treated with enzalutamide von van Soest, Robert J., de Morrée, Ellen S., de Ridder, Corrina M.A., Burger, Herman, Wiemer, Erik A.C., Mathijssen, Ron H.J., van Weerden, Wytske M., De Wit, Ronald

Volltext

Effects on androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone, and enzalutamide: Potential mechanism for cross-resistance in castration-resistant prostate canc... von van Soest, Robert J., van Royen, Martin E., de Morrée, Ellen S., Wiemer, Erik A.C., Mathijssen, Ron H.J., De Wit, Ronald, van Weerden, Wytske M.

Volltext

Mer et désert de l’Antiquité à nos jours: Approches croisées

Volltext

Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation von de Morrée, Ellen, van Soest, Robert, Aghai, Ashraf, de Ridder, Corrina, de Bruijn, Peter, Ghobadi Moghaddam-Helmantel, Inge, Burger, Herman, Mathijssen, Ron, Wiemer, Erik, de Wit, Ronald, van Weerden, Wytske

Volltext

The initial biopsy Gleason score as a predictive marker for docetaxel survival benefit in patients with prostate cancer: Data from the TAX 327 study von van Soest, Robert, de Morrée, Ellen, Shen, Liji, Tannock, Ian, Eisenberger, Mario A., De Wit, Ronald

Volltext